Diabetic Medicine

Papers
(The H4-Index of Diabetic Medicine is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
141
Letter to the editor: Nuances from the manufacturer regarding the ABCD‐DTN best practice guide on the use of MiniMed 780G advanced hybrid closed loop system72
Utility of screening for silent myocardial ischaemia in diabetes with an annual electrocardiogram59
Issue Information58
Lack of consideration of socioeconomic factors in transition programme of adolescents with type 1 diabetes: A systematic review51
Satisfaction with diabetes involvement: Exploring parent and adolescent perspectives46
Update on technologies, medicines and treatments45
Effect of switching from intermittently scanned to real‐time continuous glucose monitoring on glycaemic outcomes in adults with type 1 diabetes: A real‐world, Canadian retrospective study41
Mesenchymal stromal cell secretory molecules improve the functional survival of human islets41
Investigating health professionals' perspectives and experiences of food security‐related conversations in diabetes care38
Systematic review of technology‐mediated peer support interventions in paediatric type 1 diabetes care38
Exploring inequities in access to diabetes technologies among children and young people with type 1 diabetes: Perspectives of parents and young people from ethnic minority groups and low socio‐economi38
Autopsy of a telephone‐based peer support intervention: Exploring participants' perspectives of and experiences with a self‐management support model for adults with type 2 diabetes from speciality car34
A validation study of the Intentional Nonadherence Scale among people with type 2 diabetes in the United Kingdom32
Improving equity in diabetes technology use: Voices of youth and their parents31
Exploring low‐dose glucagon for exercise‐induced hypoglycaemia in type 1 diabetes: A randomised controlled trial31
Associations between weight self‐stigma and healthy diet and physical activity among adults with type 2 diabetes: Cross‐sectional results from the second Diabetes MILES – Australia (MILES‐2) study30
Outcomes measured in studies assessing health systems interventions for type 1 diabetes management: A scoping review29
Design, recruitment and baseline characteristics of the LENS trial28
Reply to Besançon et al. regarding ‘Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and you28
Gestational diabetes: One size does not fit all—an observational study of maternal and neonatal outcomes by maternal glucose profile27
The impact of stigma on the management of type 1 diabetes: A systematic review26
Standardising personalised diabetes care across European health settings: A person‐centred outcome set agreed in a multinational Delphi study25
Impact of diabetes stigma in diabetes distress and diabetes self‐care: The moderating role of diabetes social support and general self‐esteem in Arabic‐speaking adults with type 2 diabetes25
Management of type 1 diabetes in low‐ and middle‐income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania24
0.11587595939636